Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Sanofi-Aventis

Affiliations

  • at Regeneron Pharmaceuticals Inc. (REGN), 2020-03-11
  • Large Shareholder at Fulcrum Therapeutics Inc. (FULC), 2019-07-23
  • Large Shareholder at Myokardia Inc (MYOK), 2019-02-15
  • Large Shareholder at Alnylam Pharmaceuticals Inc. (ALNY), 2019-01-22
  • Other at Voyager Therapeutics Inc. (VYGR), 2015-11-18
  • Large Shareholder at Scynexis Inc (SCYX), 2014-05-09
  • Large Shareholder at Regulus Therapeutics Inc. (RGLS), 2014-02-05
  • Large Shareholder at Glycomimetics Inc (GLYC), 2013-11-07
  • Other at Kalobios Pharmaceuticals Inc (KBIO), 2013-02-07
  • Large Shareholder at Genzyme Corp (GENZ), 2011-04-08
  • Large Shareholder at Chattem Inc (CHTT), 2010-02-11
Insider Trading: Purchases See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
FULC $16.00 93,750 Large Shareholder 558,035 2019-07-22 Filing
MYOK $49.00 150,000 Large Shareholder 4,168,899 2018-05-25 Filing
REGN $487.01 2,557 23,880,537 2017-08-25 Filing
REGN $485.99 2,681 23,877,980 2017-08-25 Filing
REGN $485.28 5,723 23,875,299 2017-08-25 Filing
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
REGN $489.65 128,914 20,421,899 2020-03-09 Filing
REGN $281.15 172,904 20,550,813 2019-09-10 Filing
REGN $412.17 131,115 20,723,717 2019-03-08 Filing
MYOK $37.66 4,168,899 Large Shareholder 0 2019-02-13 Filing
REGN $406.68 104,552 23,654,384 2018-09-06 Filing